Novo Holdings A/S as of March 31, 2025
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 31 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 21.7 | $285M | 1.0M | 274.84 | |
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 9.3 | $122M | 2.3M | 52.41 | |
| Edgewise Therapeutics (EWTX) | 9.0 | $118M | 5.4M | 22.00 | |
| Asml Holding N V N Y Registry Shs (ASML) | 8.4 | $110M | 166k | 662.63 | |
| salesforce (CRM) | 5.6 | $73M | 273k | 268.36 | |
| Mirum Pharmaceuticals (MIRM) | 5.1 | $68M | 1.5M | 45.05 | |
| Insmed Com Par $.01 (INSM) | 4.2 | $55M | 725k | 76.29 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 3.9 | $51M | 9.7M | 5.29 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 3.7 | $49M | 372k | 132.23 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.3 | $43M | 1.3M | 33.54 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $35M | 490k | 70.69 | |
| Arrivent Biopharma (AVBP) | 2.6 | $35M | 1.9M | 18.49 | |
| Vaxcyte (PCVX) | 2.6 | $35M | 915k | 37.76 | |
| Merus N V (MRUS) | 2.5 | $33M | 789k | 42.09 | |
| Miragen Therapeutics (VRDN) | 2.3 | $30M | 2.3M | 13.48 | |
| Pharvaris N V (PHVS) | 2.1 | $27M | 1.7M | 15.70 | |
| Amicus Therapeutics (FOLD) | 1.7 | $22M | 2.8M | 8.16 | |
| Celldex Therapeutics Com New (CLDX) | 1.7 | $22M | 1.2M | 18.15 | |
| Blueprint Medicines (BPMC) | 1.5 | $20M | 229k | 88.51 | |
| Zenas Biopharma (ZBIO) | 1.3 | $18M | 2.2M | 7.90 | |
| Ceribell (CBLL) | 1.3 | $17M | 880k | 19.21 | |
| Verve Therapeutics (VERV) | 1.0 | $14M | 3.0M | 4.57 | |
| Rocket Pharmaceuticals (RCKT) | 0.6 | $7.3M | 1.1M | 6.67 | |
| 4d Molecular Therapeutics In (FDMT) | 0.5 | $6.3M | 2.0M | 3.23 | |
| Lexeo Therapeutics (LXEO) | 0.3 | $3.9M | 1.1M | 3.47 | |
| Lanzatech Global (LNZA) | 0.3 | $3.8M | 16M | 0.24 | |
| Io Biotech (IOBT) | 0.3 | $3.7M | 3.4M | 1.09 | |
| Kyverna Therapeutics (KYTX) | 0.3 | $3.6M | 1.9M | 1.93 | |
| Abcellera Biologics (ABCL) | 0.2 | $2.5M | 1.1M | 2.23 | |
| Marqeta Class A Com (MQ) | 0.1 | $1.8M | 442k | 4.12 | |
| Galecto Com New (GLTO) | 0.0 | $310k | 100k | 3.10 |
